Analia Bortolozzi

Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC)

Affiliated withSpanish National Research Council (CSIC)August Pi i Sunyer Biomedical Research Institute (IDIBAPS)Biomedical Research Networking Center for Mental Health (CIBERSAM), ISCIII

Research Area

Neuroscience

Biography

Analia Bortolozzi has not added Biography.
If you are Analia Bortolozzi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 29273501	2018
Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression. Molecular neurobiology\| PubMed ID: 30088175	2019
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys. EBioMedicine\| PubMed ID: 32810825	2020
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30PA53Tα-Synuclein Transgenic Mice. International journal of molecular sciences\| PubMed ID: 33805843	2021
Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease. Pharmacology & therapeutics\| PubMed ID: 33915178	2021
Corrigendum to "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys" [EBioMedicine 2020; 59:102944]... EBioMedicine\| PubMed ID: 34852293	2021
Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice. International journal of molecular sciences\| PubMed ID: 35163729	2022
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Translational psychiatry\| PubMed ID: 35210396	2022
Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson's disease. STAR protocols\| PubMed ID: 35707681	2022
Ketamine triggers rapid antidepressant effects by modulating synaptic plasticity in a new depressive-like mouse model based on astrocyte glutamate transporter GLT-1 knockdown in infralimbic ... Revista de psiquiatria y salud mental\| PubMed ID: 35840289	2022
Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease. International journal of molecular sciences\| PubMed ID: 35955716	2022
Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages. Frontiers in molecular biosciences\| PubMed ID: 36406277	2022
iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation. EMBO molecular medicine\| PubMed ID: 36740977	2023
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features. Biomedicines\| PubMed ID: 36831077	2023
Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington's Disease. Cellular and molecular life sciences : CMLS\| PubMed ID: 37987826	2023
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview. Pharmacological reviews\| PubMed ID: 38697859	2024
ER stress in mouse serotonin neurons triggers a depressive phenotype alleviated by ketamine targeting eIF2α signaling. iScience\| PubMed ID: 38711453	2024
New insights into the effects of serotonin on Parkinson's disease and depression through its role in the gastrointestinal tract. Spanish journal of psychiatry and mental health\| PubMed ID: 38992345	2025
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits. Nature communications\| PubMed ID: 39394193	2024
MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology\| PubMed ID: 39754785	2025
Impaired unfolded protein response, BDNF and synuclein markers in postmortem dorsolateral prefrontal cortex and caudate nucleus of patients with depression and Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry\| PubMed ID: 40015617	2025
Early synaptic changes and reduced brain connectivity in PD-like mice with depressive phenotype. NPJ Parkinson's disease\| PubMed ID: 40804075	2025
Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational neurodegeneration\| PubMed ID: 40855505	2025
The PADRIS-PRESTO cohort: A comprehensive population-based study on mental health in Catalonia. European psychiatry : the journal of the Association of European Psychiatrists\| PubMed ID: 40970440	2025
A molecular convergence in the triad of parkinson's disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis. Journal of neuroinflammation\| PubMed ID: 41188877	2025